Abstract
Bovine synthetic parathyroid hormone infused intravenously in man increased both the urinary excretion of cyclic AMP and the urinary excretion of phosphate whereas a Salmon synthetic calcitonin infusion increased the urinary excretion of phosphate without change in urinary excretion of cyclic AMP. These data are consistent with the hypothesis that different renal mechanisms are involved in the response to each hormone.
Similar content being viewed by others
References
Ardaillou, R., Fillastre, J. P., Milhaud, G.: Renal excretion of phosphate, calcium and sodium during and after a prolonged thyrocalcitonin in man. Proc. Soc. exp. Biol. (N.Y.)131, 56–60 (1960)
Caniggia, A., Gennari, C., Piantelli, F., Vattimo, A.: Initial increase of plasma radioactive calcium after intravenous injection of calcitonin in man. Clin. Sci.43, 171–180 (1972)
Caniggia, A., Gennari, C.: Early effects of calcitonin in man: comparison with the early effects of parathyroid hormone. The 5th parathyroid conference, Oxford July 21–26 1974 (in press)
Caniggia, A., Gennari, C.: The effect of calcitonins on bone47Calcium radioactivity in man (Czitober, H., Eschberger, J. ed.): Proceedings of the ICth European Symposium on Calcified Tissues, Baden (Austria), October 1st–6th, 1972, p. 131. Vienna: Facta Publication 1973
Chase, L. R., Aurbach, G. D.: Parathyroid function and the renal excretion of 3′5′-adenylic acid. Physiology58, 518–525 (1967)
Chase, L. R., Aurbach, G. D.: Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin. Science159, 545–546 (1968)
Cochran, M., Peacock, M., Sachs, G., Nordin, B. E. C.: Renal effects of calcitonin. Brit. Med. J.1, 135–137 (1970)
Fiske, C. H., Subbarow, Y.: The colorimetric determination of phosphorus. J. biol. Chem.66, 375–400 (1925)
Kaminsky, N. I., Broadus, A. E., Hardman, J. G., Jones, D. J., Ball, J. H., Jr., Sutherland, E. W., Liddle, G. W.: Effects of parathyroid hormone on plasma and urinary adenosine 3′,5′-monophosphate in man. J. clin. Invest.49, 2387–2395 (1970)
Langer, B., Peytremann, A., Rufener, C., Jenny, M.: Effets comparés de l’administration d’une dose unique de calcitonine synthétique (de type humain et de type saumon), chez l’homme normal et les sujets atteints de maladie de Paget ou d’hypercalcémie. Schweiz. med. Wschr.101, 69–80 (1971)
Murad, F.: Clinical studies and application of cyclic nucleotides. In: Greengard, P., Robison, G. A. (eds.): Advances in cyclic nucleotide research, vol. 3, p. 355. New York: Raven Press 1973
Murad, F., Brewer, H. B., Vaughan, M.: Effect of thyrocalcitonin on adenosine 3′,5′-cyclic phosphate formation by rat kidney and bone. Proc. nat. Acad. Sci. (Wash.)65, 446–453 (1970)
Nagata, N., Rasmussen, H.: Parathyroid hormone and renal cell metabolism. Biochem. (Wash.)7, 3728–3733 (1968)
Nordquist, R. E., Palmieri, G. M. A.: Intracellular localization of parathyroid hormone in the kidney. Endocrinology95, 229–237 (1974)
Paillard, F., Ardaillou, R., Malendin, H., Fillastre, J. P., Prier, S.: Renal effects of salmon calcitonin in man. J. Lab. clin. Med.80, 200–216 (1972)
Scurry, M. T., Pauk, G. L.: Renal tubular localization of parathyroid hormone induced urinary cyclic adenosine 3′,5′-monophosphate. Acta endocr. (Kbh.)77, 282–286 (1974)
Tenenhouse, A., Rassmussen, H.: Parathyroid hormone and thyrocalcitonin (calcitonin), Talmage, R. V., Bélanger, L. P. (ed.), p. 392. Amsterdam: Excerpta Medica Foundation 1968
Tomlinson, S., Barling, P. M., Albano, J. D. M., Brown, B. L., O’Riordan, J. L. H.: The effects of exogenous parathyroid hormone on plasma and urinary adenosine 3′,5′-cyclicmonophosphate in man. Clin. Sci. Mol. Med.47, 481–492 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caniggia, A., Gennari, C., Vattimo, A. et al. Early effects of synthetic bovine parathyroid hormone and synthetic salmon calcitonin on urinary excretion of cyclic AMP, phosphate and calcium in man. Calc. Tis Res. 20, 209–215 (1976). https://doi.org/10.1007/BF02546409
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02546409